The Genentech resources below are patient-friendly summaries of data related to emicizumab and safety topics. These patient-friendly summaries include studies with the strongest and most relevant data and are provided only for educational purposes. You are encouraged to discuss any questions you have about your condition and any current or potential treatments with your healthcare provider.
Select scientific data presentations with the strongest and most relevant data are provided below.
Archived data reports on thrombotic microangiopathy, serious thrombotic events, and fatalities were last updated June 30, 2020. Please note that there will be no further updates of these archived materials.
Link to Healthcare Professionals Site
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
Link to Third Party Site
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.